摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,6-bis(4-(trifluoromethyl)phenyl)pyrimidin-2-amine | 1262324-08-2

中文名称
——
中文别名
——
英文名称
4,6-bis(4-(trifluoromethyl)phenyl)pyrimidin-2-amine
英文别名
4,6-Bis[4-(trifluoromethyl)phenyl]pyrimidin-2-amine
4,6-bis(4-(trifluoromethyl)phenyl)pyrimidin-2-amine化学式
CAS
1262324-08-2
化学式
C18H11F6N3
mdl
——
分子量
383.296
InChiKey
DJRNYRITZDOYTG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    27
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    51.8
  • 氢给体数:
    1
  • 氢受体数:
    9

反应信息

  • 作为产物:
    描述:
    2-氨基-4,6-二氯嘧啶4-三氟甲基苯硼酸四(三苯基膦)钯sodium carbonate 作用下, 以 乙二醇二甲醚 为溶剂, 反应 12.0h, 以68%的产率得到4,6-bis(4-(trifluoromethyl)phenyl)pyrimidin-2-amine
    参考文献:
    名称:
    Pyrimidine Derivatives as Potent and Selective A3 Adenosine Receptor Antagonists
    摘要:
    Two regioisomeric series of diaryl 2- or 4-amidopyrimidines have been synthesized and their adenosine receptor affinities were determined in radioligand binding assays at the four human adenosine receptors (hARs). Some of the ligands prepared herein exhibit remarkable affinities (K-i < 10 nm) and, most noticeably, the absence of activity at the A(1), A(2A), and A(2B) receptors. The structural determinants that support the affinity and selectivity profiles of the series were highlighted through an integrated computational approach, combining a 3D-QSAR model built on the second generation of G Rid INdependent Descriptors (GRIND2) with a novel homology model of the hA(3) receptor. The robustness of the computational model was subsequently evaluated by the design of new derivatives exploring the alkyl substituent of the exocyclic amide group. The synthesis and evaluation of the novel compounds validated the predictive power of the model, exhibiting excellent agreement between predicted and experimental activities.
    DOI:
    10.1021/jm100843z
点击查看最新优质反应信息